Xiu Wenli,Zhao Caihong,Liu Jie,et al.Role of computer assisted surgery system in evaluating clinical outcomes of hepatic hemangioma in children[J].Journal of Clinical Pediatric Surgery,2025,(01):53-57.[doi:10.3760/cma.j.cn101785-202105003-010]
计算机辅助手术系统在评估儿童肝血管瘤转归中的应用
- Title:
- Role of computer assisted surgery system in evaluating clinical outcomes of hepatic hemangioma in children
- Keywords:
- Hepatic Hemangioma; Propranolol; Surgical Procedures; Operative; Child
- 摘要:
- 目的 探讨计算机辅助手术系统(Hisense CAS)在评估普萘洛尔治疗儿童肝血管瘤疗效中的临床价值。方法 回顾性分析2010年1月至 2020年12月于青岛大学附属医院小儿外科行口服普萘洛尔治疗的21例肝血管瘤患儿临床资料,应用Hisense CAS将患儿的CT资料进行三维重建,分析瘤体与血管关系、肝脏和瘤体体积等三维特征。结果 本研究中男12例、女9例;局灶型16例,多发型4例,弥漫型1例;肝右叶9例,肝左叶9例,累及双叶3例。普萘洛尔治疗前后肿瘤明显减小,三维重建结果显示治疗前肿瘤体积56.8(26.0,168.4)cm3,治疗后减少至10.9(8.3,22.2)cm3;治疗前肿瘤占肝脏总体积百分比为23.1%(10.7%,53.6%),治疗后降低为3.7%(2.7%,8.1%);差异均具有统计学意义(P<0.05)。普萘洛尔治疗后,肿瘤体积缩小百分比为70.0%(47.6%,89.0%),正常肝脏体积增大百分比8.3%(2.5%,14.4%)。结论 Hisense CAS三维重建在儿童肝血管瘤体积评估方面具有优势,而重建后的肝脏体积、肿瘤占肝脏体积的百分比等整体指标也为肿瘤转归的评估提供了新角度。
- Abstract:
- Objective To explore the clinical value of Hisense CAS in evaluating the efficacy of propranolol for hepatic hemangioma in children. Methods A retrospective analysis was conducted for the relevant clinical data of 21 children treated with oral propranolol Affiliated Hospital of Qingdao University from January 2010 to December 2020.Hisense CAS was utilized for reconstructing the data of computed tomography (CT) and examining the three-dimensional relationship between tumor and blood vessels,liver and tumor volume. Results There were 12 males and 9 females.Focal type in 16 cases,multitype in 4 cases,diffuse type in 1 case; There were 9 cases of right lobe of liver,9 cases of left lobe of liver,and 3 cases of bilateral lobe involved.Tumor size significantly shrank after a treatment of propranolol.Three-dimensional reconstruction results indicated that tumor volume was 56.8(26.0168.4) cm3 pre-treatment and it declined to 10.9(8.3,22.2) cm3 post-treatment.The percentage of tumor to total liver volume pre-treatment was 23.1%(10.7%,53.6%).It dropped to 3.7%(2.7%,8.1%) post-treatment and the differences were statistically significant (P<0.05).After a treatment of propranolol,percentage of tumor volume reduction was 70.0%(47.6%,89.0%) and percentage of liver volume expansion was 8.3%(2.5%,14.4%). Conclusions Hisense CAS three-dimensional reconstruction offers advantages in evaluating volume of hepatic hemangiomas in children.Reconstructed liver volume and percentage of tumor to liver volume provide a new perspective for evaluating tumor outcomes.
参考文献/References:
[1] Iacobas I, Phung TL, Adams DM, et al.Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring[J]. J Pediatr, 2018, 203:294-300.e2.DOI:10.1016/j.jpeds.2018.08.012.
[2] Gnarra M, Behr G, Kitajewski A, et al.History of the infantile hepatic hemangioma:from imaging to generating a differential diagnosis[J]. World J Clin Pediatr, 2016, 5(3):273-280.DOI:10.5409/wjcp.v5.i3.273.
[3] 詹江华, 王焕民.小儿肝血管瘤诊疗中存在的问题与挑战[J]. 中华小儿外科杂志, 2020, 41(11):961-962.DOI:10.3760/cma.j.cn421158-20200227-00121. Zhan JH, Wang HM.Problems and challenges in diagnosing and treating hepatic hemangioma in children[J]. Chin J Pediatr Surg, 2020, 41(11):961-962.DOI:10.3760/cma.j.cn421158-20200227-00121.
[4] 中华医学会小儿外科学分会肝胆外科学组, 中华医学会小儿外科学分会肿瘤学组.小儿肝血管瘤诊断和治疗专家共识[J]. 中华小儿外科杂志, 2020, 41(11):963-970.DOI:10.3760/cma.j.cn421158-20200228-00124. Section of Hepatobiliary Surgery, Branch of Pediatric Surgery, Chinese Medical Association, Section of Oncology, Branch of Pediatric Surgery, Chinese Medical Association.Expert consensus on diagnosing and treating hepatic hemangioma in children[J]. Chin J Pediatr Surg, 2020, 41(11):963-970.DOI:10.3760/cma.j.cn421158-20200228-00124.
[5] Varrasso G, Schiavetti A, Lanciotti S, et al.Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma:a case report[J]. Hepatology, 2017, 66(1):283-285.DOI:10.1002/hep.29028.
[6] Feng ST, Chan T, Ching ASC, et al.CT and MR imaging characteristics of infantile hepatic hemangioendothelioma[J]. Eur J Radiol, 2010, 76(2):e24-e29.DOI:10.1016/j.ejrad.2010.05.027.
[7] Zavras N, Dimopoulou A, Machairas N, et al.Infantile hepatic hemangioma:current state of the art, controversies, and perspectives[J]. Eur J Pediatr, 2020, 179(1):1-8.DOI:10.1007/s00431-019-03504-7.
[8] Verma A, Jain R, Babbar N, et al.Multiple infantile hepatic hemangiomas leading to consumptive hypothyroidism successfully treated with propranolol:a case report[J]. J Family Med Prim Care, 2020, 9(11):5759-5762.DOI:10.4103/jfmpc.jfmpc_1074_20.
[9] Zhang XT, Ren WD, Song G, et al.Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension[J]. BMC Cardiovasc Disord, 2019, 19(1):216.DOI:10.1186/s12872-019-1200-6.
[10] Long X, Wang YW, Zheng K, et al.Infantile hepatic haemangioendothelioma resection in a newborn:a case report and literature review[J]. J Int Med Res, 2020, 48(7):300060520934325.DOI:10.1177/0300060520934325.
[11] Pan FS, Xu M, Wang W, et al.Infantile hepatic hemangioendothelioma in comparison with hepatoblastoma in children:clinical and ultrasound features[J]. Hepat Mon, 2013, 13(8):e11103.DOI:10.5812/hepatmon.11103.
[12] Xu M, Pan FS, Wang W, et al.The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma:comparison with contrast-enhanced CT/MRI[J]. Clin Imaging, 2018, 51:311-317.DOI:10.1016/j.clinimag.2018.06.017.
[13] 段于河, 董蒨.CT三维重建及模拟手术系统在小儿肝脏外科中的应用[J]. 中华小儿外科杂志, 2015, 36(4):317-320.DOI:10.3760/cma.j.issn.0253-3006.2015.04.020. Duan YH, Dong Q.Application of CT three-dimensional reconstruction and simulation surgical system in pediatric liver surgery[J]. Chin J Pediatr Surg, 2015, 36(4):317-320.DOI:10.3760/cma.j.issn.0253-3006.2015.04.020.
[14] Tian RC, Liang Y, Wang J, et al.Propranolol for infantile hepatic hemangioendothelioma:clinical evaluation of drug efficacy and safety using a single-center patient cohort[J]. Ann Hepatol, 2020, 19(5):530-534.DOI:10.1016/j.aohep.2020.04.008.
[15] Macdonald A, Durkin N, Deganello A, et al.Historical and contemporary management of infantile hepatic hemangioma:a 30-year single-center experience[J]. Ann Surg, 2022, 275(1):e250-e255.DOI:10.1097/SLA.0000000000003881.
相似文献/References:
[1]李凯 董岿然 肖现民. 普萘洛尔治疗婴儿型血管瘤溃疡[J].临床小儿外科杂志,2013,12(05):381.
[2]邱桐,杨开颖,陈思源,等.普萘洛尔影响婴幼儿血管瘤患儿中枢神经系统功能的新进展[J].临床小儿外科杂志,2019,18(08):646.[doi:10.3969/j.issn.1671-6353.2019.08.006]
Qiu Tong,Yang Kaiying,Chen Siyuan,et al.Potential effects of propranolol on central nervous system in children with infantile hemangioma[J].Journal of Clinical Pediatric Surgery,2019,18(01):646.[doi:10.3969/j.issn.1671-6353.2019.08.006]
[3]张明,彭强,刘铭.NF-κB因子在普萘洛尔治疗裸鼠血管瘤模型过程中的表达[J].临床小儿外科杂志,2019,18(08):655.[doi:10.3969/j.issn.1671-6353.2019.08.008]
Zhang Ming,Peng Qiang,Liu Ming.Expression of NF-kappa B in propranolol treatment for infantile hemangioma in nude mice model[J].Journal of Clinical Pediatric Surgery,2019,18(01):655.[doi:10.3969/j.issn.1671-6353.2019.08.008]
[4]杨开颖,彭素华,陈思源,等.婴幼儿肝血管瘤诊治现状[J].临床小儿外科杂志,2020,19(08):746.[doi:10.3969/j.issn.1671-6353.2020.08.016]
Yang Kaiying,Peng Suhua,Chen Siyuan,et al.Current status of diagnosing and treating infantile hepatic hemangioma[J].Journal of Clinical Pediatric Surgery,2020,19(01):746.[doi:10.3969/j.issn.1671-6353.2020.08.016]
[5]王涛,刘昌荣,邓立才,等.不同β受体阻滞剂治疗婴幼儿血管瘤的疗效观察[J].临床小儿外科杂志,2024,(02):168.[doi:10.3760/cma.j.cn101785-202208021-013]
Wang Tao,Liu Changrong,Deng Licai,et al.Clinical efficacies of different types of β receptor blockers for infantile hemangioma[J].Journal of Clinical Pediatric Surgery,2024,(01):168.[doi:10.3760/cma.j.cn101785-202208021-013]
备注/Memo
收稿日期:2021-5-5。
基金项目:国家自然科学基金(82293665);青岛市关键技术攻关及产业化示范类项目(24-1-4-xxgg-16-nsh)
通讯作者:董蒨,Email:18661801885@163.com